Dipyridamole injection
Products billed under this code include Dipyridamole.
Payment limit per 10 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under this code include Dipyridamole.
Payment limit per 10 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Dipyridamole | Henry Schein Inc. | 00404-9852-10 | 5 | $42.05 |
| Dipyridamole | Hikma Pharmaceuticals USA Inc. | 00641-2569-44 | 25 | $210.25 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $8.41 | $0.00 | 10 MG | Dipyridamole injection | v1, posted September 17, 2026 |
| 3Q26 | $8.41 | $0.00 | 10 MG | Dipyridamole injection | v1, posted September 15, 2026 |
| 2Q26 | $8.41 | $0.00 | 10 MG | Dipyridamole injection | v1, posted September 15, 2026 |
| 1Q26 | $8.41 | $0.00 | 10 MG | Dipyridamole injection | v1, posted September 15, 2026 |
| 4Q25 | $8.41 | +$4.547 | 10 MG | Dipyridamole injection | v1, posted September 8, 2026 |
| 3Q25 | $3.863 | +$0.027 | 10 MG | Dipyridamole injection | v1, posted March 10, 2026 |
| 2Q25 | $3.836 | −$0.031 | 10 MG | Dipyridamole injection | v1, posted March 10, 2026 |
| 1Q25 | $3.867 | +$0.05 | 10 MG | Dipyridamole injection | v1, posted December 19, 2025 |
| 4Q24 | $3.817 | −$0.059 | 10 MG | Dipyridamole injection | v1, posted June 11, 2025 |
| 3Q24 | $3.876 | +$0.138 | 10 MG | Dipyridamole injection | v1, posted June 11, 2025 |
| 2Q24 | $3.738 | +$0.02 | 10 MG | Dipyridamole injection | v1, posted March 11, 2025 |
| 1Q24 | $3.718 | +$0.03 | 10 MG | Dipyridamole injection | v1, posted December 19, 2024 |
| 4Q23 | $3.688 | −$0.089 | 10 MG | Dipyridamole injection | v1, posted October 10, 2024 |
| 3Q23 | $3.777 | −$0.019 | 10 MG | Dipyridamole injection | v1, posted June 5, 2024 |
| 2Q23 | $3.796 | +$0.09 | 10 MG | Dipyridamole injection | v1, posted February 23, 2024 |
| 1Q23 | $3.706 | +$0.01 | 10 MG | Dipyridamole injection | v1, posted December 6, 2023 |
| 4Q22 | $3.696 | +$0.186 | 10 MG | Dipyridamole injection | v1, posted June 22, 2023 |
| 3Q22 | $3.51 | +$0.022 | 10 MG | Dipyridamole injection | v1, posted June 9, 2023 |
| 2Q22 | $3.488 | −$0.164 | 10 MG | Dipyridamole injection | v1, posted December 14, 2022 |
| 1Q22 | $3.652 | +$0.003 | 10 MG | Dipyridamole injection | v1, posted June 8, 2022 |
| 4Q21 | $3.649 | +$0.207 | 10 MG | Dipyridamole injection | v1, posted June 2, 2022 |
| 3Q21 | $3.442 | −$0.083 | 10 MG | Dipyridamole injection | v1, posted June 2, 2022 |
| 2Q21 | $3.525 | +$0.161 | 10 MG | Dipyridamole injection | v1, posted March 1, 2022 |
| 1Q21 | $3.364 | – | 10 MG | Dipyridamole injection | v1, posted December 10, 2021 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.